Difference between revisions of "WSI21-189-Case-5"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 42: Line 42:
 
|subject=Z0FBQUFBQmhlWW55a1ZITGgyNDVYMkVkNkxsSzBMOGtfeDVrN2R3UmRUSUxIQmtfUi1hcFZNNDNJaVBzby1JQ19lWm5CdmU0TmZFTHVuRXhWdnpITHJfc3ZYcVNVRGJ5Znc9PQ
 
|subject=Z0FBQUFBQmhlWW55a1ZITGgyNDVYMkVkNkxsSzBMOGtfeDVrN2R3UmRUSUxIQmtfUi1hcFZNNDNJaVBzby1JQ19lWm5CdmU0TmZFTHVuRXhWdnpITHJfc3ZYcVNVRGJ5Znc9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Hac5
 +
|authoredOn=October 26, 2021 08:18:12 PM
 
}}
 
}}

Latest revision as of 14:12, December 9, 2024

WSI21-189-Case-5
Mass
Fibrocartilaginous mesenchymoma
October 29, 2021 12:00:00 AM